OutcomesAI is a technology company.
OutcomesAI has raised $10.0M across 1 funding round.
OutcomesAI has raised $10.0M in total across 1 funding round.
OutcomesAI is a Boston-based healthtech startup founded in 2024 that builds Glia®, an AI platform combining voice agents, large multimodal models (LMMs), and large language models (LLMs) with licensed nurses to deliver scalable, safe care.[1][2][3] It serves health systems, virtual care providers, and pharma companies by addressing nurse shortages, clinical burnout, and workflow inefficiencies through applications like nurse triage, patient access, discharge navigation, smart notes, and post-acute care—claiming reductions of 50% in wait times, 30% in costs, and 40% in escalations while maintaining HIPAA/SOC 2 compliance and evidence-based protocols.[3] With 24 employees and $10M in seed funding led by Santé Ventures in late 2025, the company shows strong early momentum in AI-enabled nursing.[1][5]
OutcomesAI was founded in 2024 by Kuldeep Singh Rajput, who previously founded and led Biofourmis as CEO, bringing deep expertise in healthcare AI and remote patient monitoring.[1][2] The idea emerged from recognizing care teams' burnout and capacity constraints, leading to Glia's development as a "trusted companion" that amplifies human care rather than replacing it—starting with AI companions for workflows like triage and follow-up.[1][2] Early traction includes a $10M seed round in November 2025 led by Santé Ventures, with board support from healthcare leaders like Marvin O'Quinn (former CommonSpirit Health exec) and Joe Cunningham (Santé Ventures MD), signaling rapid validation in a nurse-shortage crisis.[2][5]
(Note: A separate entity at outcomesai.com focuses on mental health outcomes dashboards, but core references align on the Glia/nursing platform; no confirmed relation.[4])
OutcomesAI rides the AI-healthcare convergence trend, targeting a $20B+ nursing shortage amid post-pandemic burnout, where AI augments 3.5M U.S. nurses facing 200K annual vacancies.[3] Timing is ideal with maturing LLMs, voice AI, and value-based care mandates favoring scalable, cost-effective tools—market forces like rising labor costs (nursing at $100K+/year) and telehealth growth (projected $175B by 2026) amplify demand.[5] It influences the ecosystem by pioneering "human-centered AI," enabling providers to scale capacity 2-3x, reduce readmissions via better transitions, and set standards for safe AI deployment, potentially accelerating adoption in underserved areas like rural post-acute care.[2][3]
OutcomesAI is poised to expand Glia across care continuum, targeting pharma trials and global markets with its seed capital, while trends like multimodal AI advancements and regulatory clarity (e.g., FDA AI guidelines) will fuel growth.[5] Its influence may evolve from niche triage to full care orchestration, shaping a $100B AI-health market by proving ROI on hybrid models that preserve clinician trust. As Kuldeep Singh notes, this reimagines care by restoring time to patients—positioning OutcomesAI as a leader in supercharging teams without eroding the human core.[2]
OutcomesAI has raised $10.0M in total across 1 funding round.
OutcomesAI's investors include Santé Ventures, Dafina Toncheva.
OutcomesAI has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Seed in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2025 | $10.0M Seed | Santé Ventures, Dafina Toncheva |